P406: Disease clearance in patients with ulcerative colitis treated with aminosalicylatesECCO'22Year: 2022
Authors: Nascimento, C.(1);Revés, J.(1);Roque Ramos, L.(1);Carolina, P.(1);Fidalgo, C.(1);Glória, L.(1);Torres, J.(1);
(1)Hospital Beatriz Ângelo, Gastrenterology, Loures, Portugal;
P407: A Phase IB/IIA study of remestemcel-L, an allogeneic bone marrow derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: An interim analysisECCO'22Year: 2022
Authors: Lightner, A.(1);Dadgar, N.(2);Fulmer, C.(3);Ream, J.(4);Nachand, D.(4);Steele, S.(2);
(1)Cleveland Clinic, Department of Colorectal Surgery, Cleveland, United States;(2)Cleveland Clinic, Colorectal Surgery, Cleveland, United States;(3)Cleveland Clinic, Pathology, Cleveland, United States;(4)Cleveland Clinic, Radiology, Cleveland, United States;
P408: Faecal infliximab and disease activity in Acute Severe Ulcerative ColitisECCO'22Year: 2022
Authors: Shields, S.(1);Dunlop, A.(2);Gerasimidis, K.(3);Nichols, B.(3);Galloway, P.(2);Macdonald, J.(1);Hansen, R.(4);Seenan, J.P.(1);
(1)Queen Elizabeth University Hospital, Gastroenterology, Glasgow, United Kingdom;(2)Queen Elizabeth University Hospital, Biochemistry, Glasgow, United Kingdom;(3)University of Glasgow, School of Medicine- Dentistry & Nursing, Glasgow, United Kingdom;(4)Royal Hospital for Children, Gastroenterology, Glasgow, United Kingdom;
P409: FMT induced increase in gut microbial diversity and Clostridia is associated with clinical response in patients with ulcerative colitis – results from STOP Colitis trialECCO'22Year: 2022
Authors: Quraishi, M.N.(1);Quince, C.(2);Hewitt, C.(3);Beggs, A.(4);Gerasimidis , K.(5);Sharma, N.(1);Hawkey, P.(6);Oo, Y.(7);Ives, N.(3);Manzoor, S.(8);Loman, N.(6);Hansen, R.(9);Hart, A.(10);Gaya, D.(11);Iqbal, T.(1);
(1)University Hospitals Birmingham NHS Foundation Trust, Department of Gastroenterology, Birmingham, United Kingdom;(2)Earlham Institute-, Norwich Research Park, Norwich, United Kingdom;(3)Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom;(4)Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom;(5)Human Nutrition, University of Glasgow, Glasgow, United Kingdom;(6)Institute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom;(7)Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom;(8)University of Birmingham Microbiome Treatment Centre, University of Birmingham, Birmingham, United Kingdom;(9)Department of Paediatric Gastroenterology, Royal Hospital for Children Glasgow, Glasgow, United Kingdom;(10)Department of Gastroenterology, St Marks Hospital, London, United Kingdom;(11)Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom;
P410: safety of biological drugs for inflammatory bowel disease in elderly patientsECCO'22Year: 2022
Authors: Suarez Ferrer, C.J.(1);Mesonero, F.(2);Caballol, B.(3);Ballester, M.P.(4);Baston Rey, I.(5);Castaño Garcia, A.(6);Miranda Bautista, J.(7);Saiz Chumillas, R.(8);Benitez , J.M.(9);Sanchez Delgado, L.(10);Lopez-Garcia, A.(11);Rubin de Celix, C.(12);Lopez Sanroma, A.(2);Martin-Arranz, M.D.(13);Fernández-Clotet , A.(3);Merino Murgui , V.(14);Calviño Suárez , C.(15);Florez, P.(16);Lobato matilla, M.E.(7);Sicilia, B.(17);Soto Escribano, P.(18);Maroto Martin , C.(10);Alonso Abreu, I.(19);Melcarne, L.(20);Plaza Santos, R.(21);Marques Cami, M.(22);Caballero Mateos , A.(23);Gómez Díez , C.(24);Calafat, M.(25);Alonso Galan, H.(26);Vega Villaamil , P.(27);Castro Senosiain , B.(28);Guerro Moya , A.(29);Rodriguez Diaz , C.Y.(30);Spicakova, K.(31);Manceñido Marcos, N.(32);Molina, G.(33);De Castro, L.(34);Mañosa Ciria , M.(25);Barreiro-De Acosta , M.(15);
(1)Hospital Universitario La Paz, Gastroenterology Department. School of Medicine. Universidad Autónoma de Madrid. Hospital La Paz Institute forHealth Research- La Paz Hospital- Madrid, Madrid, Spain;(2)Hospital Universitario Ramon y Cajal, Gastroenterology, Madrid, Spain;(3)Hospital Clinic Barcelona, Gastroenterology, Barcelona, Spain;(4)Hospital Clinico de valencia, Gastroenterology, Valencia, Spain;(5)Hospital universitario Clinico de Santiago, Gastroenterology, Santiago de Compostela, Spain;(6)Hospital Universitario Central Asturias, Gastroenterology, Oviedo, Spain;(7)Hospital universitario Gregorio Marañon, Gastroenterology, Madrid, Spain;(8)Hospital Universitario Burgos, Gastroenterology, Burgos, Spain;(9)Hospital Reina Sofia, gastroenterology, Cordoba, Spain;(10)Hospital Universitario de Valladolid, Gastroenterology, Valladolid, Spain;(11)Hospital del Mar, gastroenterology, Barcelona, Spain;(12)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IISIP., Gastroenterology, Madrid, Spain;(13)Gastroenterology Department. School of Medicine. Universidad Autónoma de Madrid. Hospital La Paz Institute forHealth Research- La Paz Hospital, Gastroenterology, Madrid, Spain;(14)Hospital Clinico of Valencia, gastroenterology, Valencia, Spain;(15)Hospital Universitario Clínico de Santiago, Gastroenterology, Santiago de Compostela, Spain;(16)Hospital Universitario Central de Asturias, gastroenterology, Oviedo, Spain;(17)Burgos University Hospital, gastroenterology, Burgos, Spain;(18)Hospital Universitario Reina Sofia, gastroenterology, Cordoba, Spain;(19)Hospital Universitario de Canarias, Gastroenterology, Tenerife, Spain;(20)Hospital Universitari Parc Taulli- Sabadel, Gastroenterology, Barcelona, Spain;(21)Hospital Infanta Leonor Vallecas, Gastroenterology, Madrid, Spain;(22)Hospital Arnau de Vilanova, Gastroenterology, Lleida, Spain;(23)Hospital Clinico San Cecilio, gastroenterology, Granada, Spain;(24)Hospital Universitario Cabueñes, gastroenterology, Gijon, Spain;(25)Hospital Germans Trias i Pujol, gastroenterology, Badalona, Spain;(26)Hospital Universitario Donostia, gastroenterology, San Sebastian, Spain;(27)Complexo Hospitalario Universitario de Ourense, gastroenterology, Orense, Spain;(28)Hospital Universitario Marqués de Valdecilla. IDIVAL, gastroenterology, Santander, Spain;(29)Complexo Hospitalario Universitario A Coruña, gastroenterology, A Coruña, Spain;(30)Hospital Universitario Nuestra Señora de la Candelaria, gastroenterology, Tenerife, Spain;(31)Hospital Universitario de Alava, gastroenterology, Vitoria, Spain;(32)Hospital Infanta Sofia, Gastroenterology, Madrid, Spain;(33)Hospital Universitario de Ferrol, Gastroenterology, Ferrol, Spain;(34)Hospital Universitario Álvaro Cunqueiro, gastroenterology, Vigo, Spain;on belhaf of young group of GETECCU
P411: Stable pharmacokinetics and biochemical markers of inflammatory bowel disease activity: Results from a real-world adalimumab biosimilar switching programECCO'22Year: 2022
Authors: Moore, A.C.(1);Russell, D.(1);Dart, R.(1,2);Dias, S.(1);Ghuman, S.(1);Petri, B.(1);Sharma, E.(1);Ray, S.(1);Anderson, S.(1);Mawdsley, J.(1);Irving, P.M.(1);Samaan, M.A.(1);
(1)IBD Centre- St Thomas’ Hospital- NHS Foundation Trust- Westminster Bridge Road- Guy’s and St Thomas’- London- SE1 7EH- UK, Gastroenterology, London, United Kingdom;(2)Peter Gorer Dept of Immunobiology- DIIID- King’s College London- 2nd Floor Borough Wing- Guy’s Hospital- Great Maze Pond- London- SE1 9RT, Immunobiology, London, United Kingdom;
P412: Drug persistence and endoscopic, histologic and biochemical remission rates among patients following ileal pouch-anal anastomosis treated with biologic therapy: Results from a prospective patient cohort.ECCO'22Year: 2022
Authors: Ollech, J.(1);Yanai, H.(1);Avni-Biron, I.(1);Snir, Y.(1);Banai, H.(1);Broitman, Y.(1);Goren, I.(1);Wasserberg, N.(2);White, I.(2);Dotan, I.(1);
(1)Rabin Medical Center- Petah-Tikva- Israel- Sackler Faculty of Medicine- Tel Aviv University- Tel Aviv- Israel, Gastroenterology, Petach Tikva, Israel;(2)Rabin Medical Center- Petah-Tikva- Israel- Sackler Faculty of Medicine- Tel Aviv University- Tel Aviv- Israel, Surgery, Petach Tikva, Israel;
P413: Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b2 vaccines in the immunosuppressed (RESCUE)ECCO'22Year: 2022
Authors: Tran, A.P.(1,2);Tassone, D.(3,4);Nossent, J.C.(2,5);Ding, N.S.(3,4);
(1)St John of God Hospital, Wexford Medical Centre, Murdoch, Australia;(2)The University of Western Australia, School of Medicine and Pharmacology, Perth, Australia;(3)St Vincent's Hospital Melbourne, Gastroenterology, Fitzroy, Australia;(4)The University of Melbourne, Faculty of Medicine- Dentistry and Health Sciences, Parkville, Australia;(5)Sir Charles Gairdner Hospital, Department of Rheumatology, Perth, Australia;
P414: Stoma in patiens with IBD: friend or foe? -\tEffect of stoma on course of disease, psychological well-being and working capacityECCO'22Year: 2022
Authors: Bianchi, R.(1);Von Känel, R.(2);Roth, R.(3);Schreiner, P.(1);Rossel, J.B.(4);Barry, M.P.(4);Dora, B.(1);Kloth, P.(1);Juillerat, P.(5);Greuter, T.(6);Misselwitz, B.(5);Schoepfer, A.(6);Scharl, M.(1);Rogler, G.(1);Biedermann, L.(1);
(1)University Hospital Zurich and University of Zurich, Department of Gastroenterology and Hepatology, Zuerich, Switzerland;(2)University Hospital Zurich and University of Zurich, Department of Cunsultation Psychiatry and Psychosomatics, Zurich, Switzerland;(3)Spital Limmattal, Department of Internal Medicine, Schlieren, Switzerland;(4)Universiyt of Lausanne, Center for Primary Care and Public Health Unisanté, Lausanne, Switzerland;(5)Department of Visceral Surgery and Medicine, Department of Visceral Surgery and Medicine, Bern, Switzerland;(6)CHUV, Department of Gastroenterology and hepatology, Lausanne, Switzerland;
P415: Improving food‐related quality of life in Inflammatory Bowel Disease with a novel web-based intervention: a randomised controlled feasibility trialECCO'22Year: 2022
Authors: Cox, S.(1);Wall, C.(2);Clarke, H.(1);Drysdale, C.(1);Czuber-Dochan, W.(3);Lomer, M.(1);Lindsay, J.(4);Whelan, K.(1);
(1)King's College London, Department of Nutritional Sciences- Faculty of Life Sciences and Medicine, London, United Kingdom;(2)University of Otago Christchurch, Department of Medicine, Christchurch, New Zealand;(3)King's College London, Florence Nightingale Faculty of Nursing- Midwifery and Palliative Care, London, United Kingdom;(4)Barts Health NHS Trust, Department of Gastroenterology, London, United Kingdom;
P416: Addition of oral antibiotics to mechanical bowel preparation significantly improves anastomotic healing after ileocolic resection for Crohn’s diseaseECCO'22Year: 2022
Authors: Poredska, K.(1);Kunovský, L.(2);Marek, F.(2);Kala, Z.(2);Ivanecká, D.(2);Iesalnieks, I.(3);
(1)University Hospital Brno, Department of Gastroenterology and Internal Medicine, Masaryk University, Faculty of Medicine, Brno, Czech Republic;(2)University Hospital Brno, Department of Surgery, Masaryk University, Faculty of Medicine, Brno, Czech Republic;(3)Evangelisches Krankenhaus Kalk, Department of Surgery, Cologne, Germany;
P418: Development and validation of a digital health platform (IBD NutriCare) for telenutrition in patients with Inflammatory bowel diseaseECCO'22Year: 2022
Authors: Gupta, A.(1);Singh, N.(1);Madan, D.(1);Farooqui, M.(1);Singh, N.(1);Singh, M.(1);Virmani, S.(1);Verma, M.(1);Bajaj, A.(1);Markandey, M.(1);kante, B.(1);Vuyyuru, S.K.(1);Kumar, P.(1);Sahu, P.(1);Makharia, G.(1);Kedia, S.(1);Ahuja, V.(1);
(1)All India Institute of Medical Science, Department of Gastroenterology and Human Nutrition Unit, New Delhi, India;
P419: Long-term outcome of ulcerative colitis in pediatric patients who achieved mucosal and histological healing: a real-life referral center experienceECCO'22Year: 2022
Authors: Scarallo, L.(1);Peruggia, E.(2);Fioretti, L.(1);Renzo, S.(1);Paci, M.(1);Naldini, S.(1);Barp, J.(1);Di Paola, M.(1);Lionetti, P.(1,3);
(1)Meyer Children Hospital, Gastroenterology and Nutrition Unit, Florence, Italy;(2)University of Florence, Faculty of Medicine and Surgery, Florence, Italy;(3)University of Florence, Department of NEUROFARBA, Florence, Italy;
P420: Long term efficacy of ustekinumab in Crohn's disease patients after vedolizumab failureECCO'22Year: 2022
Authors: Melotti, L.(1);Dussias, N.K.(1);Belluzzi, A.(1);Salice, M.(1);Calabrese, C.(1);Rizzello, F.(1);Gionchetti, P.(1);
(1)University of Bologna, Dept of surgical and medical sciences, Bologna, Italy;
P422: How achievable are the STRIDE-II treatment targets in real-world practise and do they affect outcome?ECCO'22Year: 2022
Authors: Routledge, E.(1);Meade, S.(1);Sharma, E.(1);Zeki, S.(1);Ray, S.(1);Anderson, S.(1);Sanderson, J.(1);Mawdsley, J.(1);Samaan, M.(1);
(1)Guys and St Thomas' NHS Foundation Trust, Gastroenterology, London, United Kingdom;
P423: Azathioprine still remains the first step-up therapy in patients with Inflammatory Bowel Disease in low-middle income countries.ECCO'22Year: 2022
Authors: Ranjan, M.K.(1);Kumar, P.(1);Vuyyuru, S.K.(1);Kante, B.(1);Sahu, P.(1);Mundhra, S.(1);Golla, R.(1);Singh, M.(1);Virmani, S.(1);Sharma, R.(1);Panwar, R.(1);Das, P.(1);Makharia, G.(1);Kedia, S.(1);Ahuja, V.(1);
(1)All India Institute of Medical Sciences, Department of Gastroenterology and Human Nutrition, New Delhi, India;
